Searched over 200M research papers
10 papers analyzed
These studies suggest that lisinopril effectively lowers blood pressure in various populations, with dose-dependent effects and greater reductions in systolic blood pressure compared to some other antihypertensives.
18 papers analyzed
Lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, is widely used to manage hypertension. Understanding the specific impact of a 40 mg dose on blood pressure is crucial for optimizing treatment plans for hypertensive patients.
Several studies have evaluated the efficacy of lisinopril in reducing blood pressure. A study comparing lisinopril (10 to 40 mg) with atenolol (50 to 100 mg) found that lisinopril significantly reduced seated blood pressure by 26/15 mm Hg, compared to 19/14 mm Hg with atenolol, indicating a superior reduction in systolic blood pressure with lisinopril. Another study focusing on hypertensive patients undergoing hemodialysis reported a decrease in mean ambulatory blood pressure from 149/84 mm Hg to 127/73 mm Hg, a reduction of 22/11 mm Hg, with doses up to 40 mg of lisinopril.
In a multicenter study comparing lisinopril (10, 20, or 40 mg once daily) with captopril (25, 50, or 100 mg twice daily), lisinopril demonstrated a more significant reduction in blood pressure over 24 hours, highlighting its efficacy in sustained blood pressure control. Additionally, a dose-response study in children showed that higher doses of lisinopril, including 40 mg, effectively lowered blood pressure in a dose-dependent manner.
The CALM II study, which assessed the long-term effects of high-dose lisinopril (40 mg) in combination with candesartan, found that both treatment regimens significantly reduced systolic blood pressure, with no significant difference between the dual-blockade and high-dose lisinopril alone. This suggests that 40 mg of lisinopril is effective in long-term blood pressure management and is well-tolerated.
A retrospective cohort study comparing once-daily (40 mg) and twice-daily (20 mg) dosing of lisinopril found that twice-daily administration was associated with a greater reduction in systolic blood pressure (16.5/5.9 mm Hg) compared to once-daily dosing (6.2/1.5 mm Hg). This indicates that splitting the dose may enhance blood pressure control in some patients.
Overall, 40 mg of lisinopril effectively lowers blood pressure, with reductions ranging from 22/11 mm Hg to 26/15 mm Hg in various patient populations . It is well-tolerated and provides sustained blood pressure control, making it a viable option for managing hypertension. However, individual responses may vary, and some patients might benefit from a twice-daily dosing regimen for optimal blood pressure reduction.
Most relevant research papers on this topic